TNF and neoplasm: This “silver bullet” against cancer seemed close at hand in 1995 when tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL/Apo2L) was introduced [1,2] and later shown to selectively induce apoptosis in tumour cells in vivo [3,4].